The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Orally Disintegrating Tablet (ODT) Market Research Report 2025
Synopsis
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The global Orally Disintegrating Tablet (ODT) market was valued at US$ 13890 million in 2023 and is anticipated to reach US$ 17760 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet (ODT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet (ODT).
Report Scope
The Orally Disintegrating Tablet (ODT) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orally Disintegrating Tablet (ODT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablet (ODT) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Disintegrating Tablet (ODT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Disintegrating Tablet (ODT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The global Orally Disintegrating Tablet (ODT) market was valued at US$ 13890 million in 2023 and is anticipated to reach US$ 17760 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet (ODT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet (ODT).
Report Scope
The Orally Disintegrating Tablet (ODT) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orally Disintegrating Tablet (ODT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablet (ODT) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Disintegrating Tablet (ODT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Disintegrating Tablet (ODT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Orally Disintegrating Tablet (ODT) Market Overview
1.1 Product Overview and Scope of Orally Disintegrating Tablet (ODT)
1.2 Orally Disintegrating Tablet (ODT) Segment by Type
1.2.1 Global Orally Disintegrating Tablet (ODT) Market Value Comparison by Type (2024-2030)
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Others
1.3 Orally Disintegrating Tablet (ODT) Segment by Application
1.3.1 Global Orally Disintegrating Tablet (ODT) Market Value by Application: (2024-2030)
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Others
1.4 Global Orally Disintegrating Tablet (ODT) Market Size Estimates and Forecasts
1.4.1 Global Orally Disintegrating Tablet (ODT) Revenue 2019-2030
1.4.2 Global Orally Disintegrating Tablet (ODT) Sales 2019-2030
1.4.3 Global Orally Disintegrating Tablet (ODT) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Orally Disintegrating Tablet (ODT) Market Competition by Manufacturers
2.1 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Orally Disintegrating Tablet (ODT) Average Price by Manufacturers (2019-2024)
2.4 Global Orally Disintegrating Tablet (ODT) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Orally Disintegrating Tablet (ODT), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orally Disintegrating Tablet (ODT), Product Type & Application
2.7 Orally Disintegrating Tablet (ODT) Market Competitive Situation and Trends
2.7.1 Orally Disintegrating Tablet (ODT) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Orally Disintegrating Tablet (ODT) Players Market Share by Revenue
2.7.3 Global Orally Disintegrating Tablet (ODT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orally Disintegrating Tablet (ODT) Retrospective Market Scenario by Region
3.1 Global Orally Disintegrating Tablet (ODT) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Orally Disintegrating Tablet (ODT) Global Orally Disintegrating Tablet (ODT) Sales by Region: 2019-2030
3.2.1 Global Orally Disintegrating Tablet (ODT) Sales by Region: 2019-2024
3.2.2 Global Orally Disintegrating Tablet (ODT) Sales by Region: 2025-2030
3.3 Global Orally Disintegrating Tablet (ODT) Global Orally Disintegrating Tablet (ODT) Revenue by Region: 2019-2030
3.3.1 Global Orally Disintegrating Tablet (ODT) Revenue by Region: 2019-2024
3.3.2 Global Orally Disintegrating Tablet (ODT) Revenue by Region: 2025-2030
3.4 North America Orally Disintegrating Tablet (ODT) Market Facts & Figures by Country
3.4.1 North America Orally Disintegrating Tablet (ODT) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Orally Disintegrating Tablet (ODT) Sales by Country (2019-2030)
3.4.3 North America Orally Disintegrating Tablet (ODT) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orally Disintegrating Tablet (ODT) Market Facts & Figures by Country
3.5.1 Europe Orally Disintegrating Tablet (ODT) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Orally Disintegrating Tablet (ODT) Sales by Country (2019-2030)
3.5.3 Europe Orally Disintegrating Tablet (ODT) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orally Disintegrating Tablet (ODT) Market Facts & Figures by Country
3.6.1 Asia Pacific Orally Disintegrating Tablet (ODT) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Orally Disintegrating Tablet (ODT) Sales by Country (2019-2030)
3.6.3 Asia Pacific Orally Disintegrating Tablet (ODT) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Orally Disintegrating Tablet (ODT) Market Facts & Figures by Country
3.7.1 Latin America Orally Disintegrating Tablet (ODT) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Orally Disintegrating Tablet (ODT) Sales by Country (2019-2030)
3.7.3 Latin America Orally Disintegrating Tablet (ODT) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orally Disintegrating Tablet (ODT) Market Facts & Figures by Country
3.8.1 Middle East and Africa Orally Disintegrating Tablet (ODT) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Orally Disintegrating Tablet (ODT) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Orally Disintegrating Tablet (ODT) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Orally Disintegrating Tablet (ODT) Sales by Type (2019-2030)
4.1.1 Global Orally Disintegrating Tablet (ODT) Sales by Type (2019-2024)
4.1.2 Global Orally Disintegrating Tablet (ODT) Sales by Type (2025-2030)
4.1.3 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Type (2019-2030)
4.2 Global Orally Disintegrating Tablet (ODT) Revenue by Type (2019-2030)
4.2.1 Global Orally Disintegrating Tablet (ODT) Revenue by Type (2019-2024)
4.2.2 Global Orally Disintegrating Tablet (ODT) Revenue by Type (2025-2030)
4.2.3 Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Type (2019-2030)
4.3 Global Orally Disintegrating Tablet (ODT) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Orally Disintegrating Tablet (ODT) Sales by Application (2019-2030)
5.1.1 Global Orally Disintegrating Tablet (ODT) Sales by Application (2019-2024)
5.1.2 Global Orally Disintegrating Tablet (ODT) Sales by Application (2025-2030)
5.1.3 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Application (2019-2030)
5.2 Global Orally Disintegrating Tablet (ODT) Revenue by Application (2019-2030)
5.2.1 Global Orally Disintegrating Tablet (ODT) Revenue by Application (2019-2024)
5.2.2 Global Orally Disintegrating Tablet (ODT) Revenue by Application (2025-2030)
5.2.3 Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Application (2019-2030)
5.3 Global Orally Disintegrating Tablet (ODT) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Orally Disintegrating Tablet (ODT) Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Orally Disintegrating Tablet (ODT) Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Orally Disintegrating Tablet (ODT) Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Orally Disintegrating Tablet (ODT) Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Johnson and Johnson
6.5.1 Johnson and Johnson Corporation Information
6.5.2 Johnson and Johnson Description and Business Overview
6.5.3 Johnson and Johnson Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson and Johnson Orally Disintegrating Tablet (ODT) Product Portfolio
6.5.5 Johnson and Johnson Recent Developments/Updates
6.6 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GSK Orally Disintegrating Tablet (ODT) Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Otsuka
6.6.1 Otsuka Corporation Information
6.6.2 Otsuka Description and Business Overview
6.6.3 Otsuka Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Otsuka Orally Disintegrating Tablet (ODT) Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Eli Lilly and Company
6.8.1 Eli Lilly and Company Corporation Information
6.8.2 Eli Lilly and Company Description and Business Overview
6.8.3 Eli Lilly and Company Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eli Lilly and Company Orally Disintegrating Tablet (ODT) Product Portfolio
6.8.5 Eli Lilly and Company Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Corporation Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AstraZeneca Orally Disintegrating Tablet (ODT) Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet (ODT) Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 Conquer
6.11.1 Conquer Corporation Information
6.11.2 Conquer Orally Disintegrating Tablet (ODT) Description and Business Overview
6.11.3 Conquer Orally Disintegrating Tablet (ODT) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Conquer Orally Disintegrating Tablet (ODT) Product Portfolio
6.11.5 Conquer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orally Disintegrating Tablet (ODT) Industry Chain Analysis
7.2 Orally Disintegrating Tablet (ODT) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orally Disintegrating Tablet (ODT) Production Mode & Process
7.4 Orally Disintegrating Tablet (ODT) Sales and Marketing
7.4.1 Orally Disintegrating Tablet (ODT) Sales Channels
7.4.2 Orally Disintegrating Tablet (ODT) Distributors
7.5 Orally Disintegrating Tablet (ODT) Customers
8 Orally Disintegrating Tablet (ODT) Market Dynamics
8.1 Orally Disintegrating Tablet (ODT) Industry Trends
8.2 Orally Disintegrating Tablet (ODT) Market Drivers
8.3 Orally Disintegrating Tablet (ODT) Market Challenges
8.4 Orally Disintegrating Tablet (ODT) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
